Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
EJHaem 2024 Aug
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia.
Related Questions
Would you give GO and/or a FLT3 inhibitor for patients with AML with t(8;21) and FLT3-ITD low in addition to 7+3?
Is there any data on combining the two?
24510
×
To continue please login or register
Register
or
Sign in
